RWE Connect
Home › Upcoming Conferences › London 2027
London · UK EditionRegistration Open

RWE Connect London 2027

13 to 14 April 2027Central London, venue to be announcedTwo days, one track

Transforming Evidence Into Market Access and Healthcare Value: the MHRA and the ABPI on stage with the global HEOR, market access and evidence leads whose work they assess.

Doors Open In
000
Days
00
Hours
00
Minutes
00
Seconds
Scroll
21Speakers confirmed
2Regulatory and policy bodies on stage
17Sessions published so far
17Organizations represented on stage
About This Edition

Evidence That Earns Access

RWE Connect London 2027 brings together pharmaceutical, biotechnology, healthcare, regulatory and technology leaders to explore the evolving role of real-world evidence in accelerating healthcare innovation and improving patient outcomes.

As life sciences organizations face increasing pressure to demonstrate treatment value, optimize market access strategies and generate meaningful evidence beyond clinical trials, the programme focuses on next-generation evidence strategies, global HTA expectations, payer requirements, AI-driven analytics, digital health insights and the future of value demonstration.

Day 1 Theme

Transforming Evidence Into Market Access and Healthcare Value

Day 2 Theme

Innovation, Analytics and the Future of Real-World Evidence

Programme Themes
Advancing RWE Strategies for Global Market AccessReal-World Data Quality, Governance and StandardizationDigital Health Data and Next-Generation Evidence ModelsPatient-Centric Evidence GenerationValue-Based Healthcare and Outcomes ResearchRegulatory Acceptance of RWEFuture of HEOR and Evidence StrategyAI and Advanced Analytics in Evidence GenerationRWE Integration Across the Product LifecycleStrengthening Evidence for HTA and Reimbursement Decisions
Why Attend

What You Leave With

Two days built around the decisions your evidence has to survive, not around the volume of content.

01

A Benchmark for Your Evidence Plan

Hear how global HEOR, value and access leads at AstraZeneca, BMS, Teva and Takeda build decision-ready evidence, and measure your own plan against theirs.

02

The Standards Before You Need Them

Learn what the regulator and the industry body expect from real-world data before your next submission or dossier goes in.

03

Working Examples, Not Theory

Rare disease evidence, patient-centred outcomes, medical affairs redesign and data science at Novo Nordisk, presented by the people who ran them.

04

Your Peers, Not Your Vendors

Registrations are qualified and vendor attendance is capped, so the room stays majority pharma, biotech, regulator and payer.

Who Should Attend

Who Will Be in the Room

Where Delegates Travel From

United Kingdom55%
Rest of Europe30%
North America and rest of world15%

By Industry

Biotech and pharma professionals58%
Academic and research roles13%
Health systems, payers and practitioners13%
Government, regulatory and HTA8%
Technology providers and consultants5%

Roles the Programme Is Written For

Pharmaceutical and Biotechnology CompaniesGlobal RWE Strategy LeadersReal-World Data ScientistsHEOR ProfessionalsMarket Access and Pricing LeadersValue Evidence TeamsMedical Affairs ProfessionalsClinical Development ExpertsEpidemiologists and BiostatisticiansRegulatory Strategy LeadersDigital Health and AI InnovatorsPayers and HTA Stakeholders
Organizations Confirmed on Stage
AstraZenecaGSKBristol Myers SquibbTeva PharmaceuticalsTakedaUCBRoche DiagnosticsBioMarinAstellas Pharma EuropeAdvanzPharmaBoehringer IngelheimNovo NordiskAbbVieNovartisGilead Sciences
Agenda at a Glance

Two Days in London

Sessions confirmed so far. Everything up to the morning break is public on each day; the rest of the programme is sent on request.

Day 1Tuesday, 13 April 2027
08:00Registration and Networking Breakfast
08:55Opening Remarks by the Chairperson
09:00Keynote: Regulatory Perspectives on Real World Evidence Keynote
09:30Building Effective RWE Strategies for Global Market Access
10:00RWE as a Value Driver Across the Pharmaceutical Lifecycle
10:30Morning Refreshments and Networking
11:15Designing Decision-Ready Evidence: The Evolving Role of Medical Affairs
11:45From Better Health to Greater Societal Value: The Role of Patient-Centred Evidence
12:15Agentic AI for PV and RWE: Expectations, Readiness and the Ways Forward
13:00Networking Lunch and Poster Presentations
14:00Market Access From the Inside: A View of Market Access and Its Future
14:30RWD in Clinical Development: Accelerating Trials and Improving Decisions
15:00Afternoon Refreshments and Partner Meetings
15:45Panel: The Future of Evidence-Based Market Access Panel
16:45Closing Remarks by the Chairperson
17:00Drinks Reception and Networking
6 more sessions on Day 1Request the Full Agenda
Day 2Wednesday, 14 April 2027
08:00Registration and Morning Coffee
08:55Opening Remarks by the Chairperson
09:00Keynote: RWE as a Value Driver Across the Pharmaceutical Lifecycle Keynote
09:30Real-World Evidence in Regulatory Decision Making
10:00Building Effective RWE Strategies for Global Market Access
10:30Morning Refreshments and Poster Presentations
11:15Session to Be Announced
11:45When Every Patient Counts: The Role of Real-World Evidence in Rare Disease Development
12:15Networking Lunch and Roundtable Discussions
13:15Rethinking Your Launch Sequencing
13:45Session to Be Announced
14:15Panel Discussion: Topic to Be Announced Panel
14:45Closing Remarks by the Chairperson
15:00Evening Refreshments and Networking Close
5 more sessions on Day 2Request the Full Agenda
Networking

Where the Conversations Happen

Both days · booked in advance

One-to-One Meeting Diary

Pick the delegates you want to meet ten days out; we schedule them into the refreshment and partner meeting breaks.

Day 1 · 13:00

Poster Lunch

Lunch alongside poster presentations from delegates and sponsors, with authors at their boards.

Day 2 · 12:15

Roundtable Lunch

Tables by topic, each hosted by a speaker, so the morning's sessions continue over lunch.

Day 1 · 17:00

Drinks Reception

Every delegate, every speaker and every sponsor in one room to close the first day.

Sponsors and Partners

Backing London 2027

Be the First Name on This Page

Sponsorship for London 2027 has opened, and the Headline position is still available. Packages run from Headline, Platinum, Gold and Silver to Thought Leadership and Exhibitor, plus standalone meeting and branding options.

Why Sponsor

Why Sponsor London 2027

Sponsorship at RWE Connect is priced on access, not on banner space. Four things a partner gets that a stand at a large congress cannot offer.

Stage

A Session Every Delegate Hears

Your speaking slot sits inside the single track. There is no parallel room, so the whole audience is in front of you.

Leads

The Delegate List Before Day One

Sponsors receive attendee details ahead of the summit, so commercial conversations start before the first session opens.

Access

Regulators and Payers at the Same Tables

The people your customers have to convince are in the room, at the roundtables and at the reception, not name-checked on a slide.

Reach

Visibility That Outlasts the Two Days

Website, email campaigns and on-site branding before and during, then the post-show report to every delegate after.

Venue and City

Why London

01

The Regulator and the HTA Body Are Here

The MHRA and NICE are both London-based, which is why they can be on stage rather than quoted.

02

Europe's Largest Life Sciences Cluster

The Golden Triangle of London, Oxford and Cambridge puts the UK and European HQs of most global pharma within an hour.

03

Reachable in a Day From Anywhere

Six airports, the Eurostar from Paris, Brussels and Amsterdam, and direct flights from Boston, New York and the US East Coast.

Venue

To Be Announced

A central London venue is being confirmed. Registered delegates are the first to hear, and the venue, room block and travel notes are added here on announcement.

Travel Notes

Day 2 finishes mid-afternoon so that delegates can travel home the same evening. A hotel room block at a negotiated rate will be offered once the venue is confirmed.

Previous Edition

See What Happened in Boston

London builds on the inaugural edition. The delivered agenda, the speakers and the post-show report are on the Boston 2026 page.

Is the programme the same as Boston?

No. Each edition is researched with the leaders in its region. London is built around UK and European access, HTA and regulatory questions, with the MHRA and the ABPI on stage.

Are sessions recorded?

Sessions are not recorded or streamed. The full agenda is available on request, and the post-show report summarizes the discussion for every delegate and sponsor after the summit.

What is the dress code and language?

Business attire. All sessions are in English.

Can I bring a colleague for one day?

Passes cover both days and are personal to the holder, but a pass can be transferred to a colleague at any time by writing to the delegate team.

Take Part

Be in the Room in London

Register as a delegate, put your organization on the main stage, or propose a session.

Register for London 2027